Diagnosing or predicting the course of breast cancer

Details for Australian Patent Application No. 2005250479 (hide)

Owner Veridex, LLC

Inventors Atkins, David; Backus, John; Belly, Robert; White, Robert; Rosen, Steve

Agent Callinan

Pub. Number AU-B-2005250479

PCT Pub. Number WO2005/118875

Priority 60/577,155 04.06.04 US

Filing date 6 June 2005

Wipo publication date 15 December 2005

Acceptance publication date 22 July 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12P 19/34 (2006.01) Preparation of compounds containing saccharide radicals

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/118875 Priority application(s): WO2005/118875

22 July 2010 Application Accepted

  Published as AU-B-2005250479

18 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005250481-The use of sized barite as a weighting agent for drilling fluids

2005250478-Inhibitors of REGIII proteins as asthma therapeutics